Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...

When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory ...

(By Dr. Mandeep Singh Malhotra) Cancer still remains a prominent cause of mortality across the globe. Despite recent breakthroughs in the treatment strategies, the understanding of how cancer begins ...

An investigation by researchers from Case Western Reserve University School of Medicine in the US has filled in a missing link between the toxic build-up of proteins in the neurodegenerative condition ...

EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...

OMEICOS, a clinical-stage biopharmaceutical company developing first-in-class small molecule therapeutics for mitochondrial and inflammatory disorders, announced the successful conclusion of its multi ...

Study findings map out a new way in which antiviral signals engage with cellular metabolism to balance defense and repair.

The £1.1m Rosetta Stone study hopes to make a breakthrough by comparing both conditions.

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that ...

Virginia Tech researchers have discovered an indication hidden in the brain that may help doctors identify children suffering ...

Glowing masks make for social-media friendly selfies, but red light therapy has potential beyond content fodder. Brands and ...

Researchers have discovered that a naturally occurring molecule in the human body plays a key role in reducing stress, a breakthrough that could pave the way for new treatments for metabolic disorders ...